BioLife Solns BLFS reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
BioLife Solns beat estimated earnings by 38.1%, reporting an EPS of $-0.13 versus an estimate of $-0.21.
Revenue was up $9.33 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.06 which was followed by a 7.8% increase in the share price the next day.
Here's a look at BioLife Solns's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -0.250 | -0.17 | -0.09 | -0.07 |
EPS Actual | -0.191 | -0.32 | -0.19 | 0 |
Revenue Estimate | 38.20M | 35.81M | 31.61M | 27.55M |
Revenue Actual | 36.22M | 37.30M | 33.80M | 31.20M |
To track all earnings releases for BioLife Solns visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.